Form D · Other
Sequence Bioinformatics Inc.
St. Johns, A4 · CIK 0001679588
Offering snapshot reported Jul 30, 2019 · SEC filing
- Reported sold
- $1.32M Offering amount: $1.32M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 19, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 30, 2019 | Initial | $1,316,482 | No comparison | 2 | SEC filing |
| Jul 14, 2016 | Initial | $1,600,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-345408
Source: Form D, filed Jul 30, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Dobbin | Director |
| Andrew Furey | Director |
| Chris Gardner | Director, Executive |
| James Hardiman | Director |
| Tyler Wish | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
139 Water Street 2 Nd Floor
St. Johns, A4, A1C 1B2
St. Johns, A4, A1C 1B2